Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
54 participants
OBSERVATIONAL
2025-01-30
2025-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Different Sealers and Activation Methods on Pain
NCT06860191
Post-endodontic Pain Survey
NCT04462731
Postoperative Pain After the Use of Different Root Canal Sealers
NCT03919318
Effect of Different Root Canal Sealers on Postoperative Pain
NCT06726837
Effect of Resin, Calcium Silicate and Silicone Based Root Canal Sealers on Postoperative Pain
NCT05033093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
powder-liquid MTA
The root canal will be filled with MTA at the end of the first session and patients will fill out a post-op pain form for 1 week.
MTA
MTA is primarily composed of tricalcium silicate, dicalcium silicate, bismuth oxide (for radiopacity), and small amounts of calcium sulfate. MTA is highly biocompatible, making it suitable for use in the root canal system and areas in close contact with tissues.
Putty MTA
The root canal will be filled with putty MTA at the end of the first session and patients will fill out a post-op pain form for 1 week.
MTA
MTA is primarily composed of tricalcium silicate, dicalcium silicate, bismuth oxide (for radiopacity), and small amounts of calcium sulfate. MTA is highly biocompatible, making it suitable for use in the root canal system and areas in close contact with tissues.
Epoxy resin sealer
The root canal will be filled with epoxy resin sealer and gutta-percha at the end of the first session and patients will fill out a post-op pain form for 1 week.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MTA
MTA is primarily composed of tricalcium silicate, dicalcium silicate, bismuth oxide (for radiopacity), and small amounts of calcium sulfate. MTA is highly biocompatible, making it suitable for use in the root canal system and areas in close contact with tissues.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* large pulp perforation during caries removal,
* inflamed pulp in which bleeding could not be controlled within 5 min,
* periodontally healthy mature mandibular first or second molar tooth.
Exclusion Criteria
* had a positive history of antibiotic use during the past 1 month,
* required antibiotic prophylaxis
* used analgesic within 7 days prior to the beginning of treatment,
* were allergic to the materials used during root canal treatment,
* if the bleeding could be controlled within 5 min and vital pulp treatment could be performed,
* the tooth had negative response to vitality tests and/or was symptomatic,
* had an associated periapical lesion visible on a radiograph,
* needed a post-core or was planned to serve as prosthetic support,
* had a calcified root canal and internal or external root resorption,
* had tooth with open apex
* mandibular third molars
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TC Erciyes University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayşe Tuğba Eminsoy Avcı
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erciyes University Faculty of Dentistry
Kayseri, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAvci
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.